11 – 16 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2020
-
Mark
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Expression of PD-L1 and PD-1 in chemoradiotherapy-Naïve esophageal and gastric adenocarcinoma : Relationship with mismatch repair status and survival
(
- Contribution to journal › Article
-
Mark
The immune microenvironment of colorectal cancer - Relationship with survival, sidedness, and pre-diagnostic anthropometry
(
- Thesis › Doctoral thesis (compilation)
- 2018
-
Mark
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
(
- Contribution to journal › Article
- 2007
-
Mark
No evidence of association between genetic variants of the PDCD1 ligands and SLE
(
- Contribution to journal › Article
- 2006
-
Mark
Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »